{ "FLT PET Imaging in Patients With Cancer", "This study is looking at a special type of imaging called 3'-deoxy-3'-[18F]fluorothymidine (FLT) PET imaging in people with cancer. Doctors inject a small amount of a tracer compound called \[F-18\] FLT into your veins, and then you have a PET scan for about two hours. This helps measure how fast tumors are growing. The main goal is to see how well FLT PET imaging can measure tumor growth and a process called DNA synthesis. Researchers also want to see if this imaging can help find tumors and predict how well treatments will work. You can join if you are 18 to 120 years old, have a confirmed solid tumor or blood cancer, or are awaiting a biopsy for a suspected cancer. You must also be able to lie still for the scan and not be pregnant or breastfeeding. The current recruitment status is unclear.", "design": "This is an interventional study, meaning participants will receive a specific intervention (FLT PET imaging). It is not specified if it's randomized or blinded, or the planned number of participants.", "commitments": "You would undergo up to four 3'-deoxy-3'-\[18F\] fluorothymidine PET imaging procedures. Each procedure involves an injection and a 2-hour PET scan.", "compensation": "Not stated in the trial record.", "follow_up": "Changes in certain markers are measured before and after therapy, but the overall follow-up duration is not specified." }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.